Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy-Reference-Cited by-同舟云学术

Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Published:2020-12 Issue:12 Volume:46 Page:2283-2291
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Birgisson Helgi^ORCID,Enblad Malin^ORCID,Artursson Sara,Ghanipour Lana,Cashin Peter^ORCID,Graf Wilhelm

Funder

Swedish Cancer Foundation

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference28 articles.

1. A perspective on clinical research strategies in carcinoma of the large bowel;Sugarbaker;World J Surg,1991

2. Clinical delivery system for intraperitoneal hyperthermic chemotherapy;Spratt;Canc Res,1980

3. Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases;Simkens;Eur J Surg Oncol,2016

4. CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: the small-bowel PCI score as a predictor of survival;Spiliotis;Pleura Peritoneum,2019

5. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy;Hallam;Br J Surg,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic impact of surgical staging procedures in patients with colorectal and appendiceal peritoneal metastases undergoing CRS-HIPEC;2024-02-01

2. Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy;World Journal of Surgery;2024-01-09

3. Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer;Cancers;2023-11-29

4. Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin;Annals of Surgical Oncology;2023-11-21

5. Should we exclude patients with peritoneal carcinosis of colorectal origin and high PCI from CRS + HIPEC?;Updates in Surgery;2023-07-09